Furthermore, they identified the DNA-damage sensor kinase ataxia telangiectasia and Rad3-related (ATR) as a MYB downstream target that is overexpressed in primary ACCs and ACC-patient-derived xenografts [24]. This evidence concerns the gene ATR and adrenal cortex carcinoma.